CHEMICAL/BIOLOGICAL DEFENSE (ACD&P)

Abstract

Operational forces have an immediate need to survive, safely operate, and sustain operations in a Chemical and Biological (CB) agent threat environment across the continuum of global, contingency, special operations/low intensity conflict, counternarcotics, and other high risk missions. This program element supports the Advanced Component Development and Prototypes (ACD&P) of CB defensive equipment, both medical and non-medical. DoD missions for civil support operations have recently expanded and have resulted in providing focus to develop technologies to support CB counterterrorism initiatives. Projects within BA4 have been structured to consolidate Joint and Service-unique tasks within four commodity areas: contamination avoidance, force protection (individual and collective), decontamination, and medical countermeasures. ACD&P is conducted for an array of chemical/biological/toxin detection and warning systems providing early warning, collector concentrators, generic detection, improved reagents, and decontamination systems using solutions that will remove and/or detoxify contaminated material without damaging combat equipment, personnel or the environment. In the medical chemical/biological defense area, ACD&P is conducted for improved medical equipment, vaccines, and drugs essential to counteracting lethal and human performance degrading effects of chemical and biological agent threats. Specific items include improvements to nerve agent antidotes, anticonvulsants, biological agent diagnostics, and vaccines to protect against various Biological Warfare (BW) agents. This project funds development of a Transformational Rapid Drug Discovery and Development Capability (TRDDDC). Transformational Medical Technology Initiatives (TMTI) efforts in this area will include the continual build out of both a genomic sequencing and a bio-chemical informatics capability for the DoD. ACD&P also supports the Product Director Test Equipment, Strategy and Support (PD TESS) providing for the development of updated test capabilities to evaluate Chemical, Biological, Radiological and Nuclear Defense systems. Also included is the Techbase Technology Transition effort which validates high-risk/high-payoff technologies that could significantly improve warfighter capabilities. This project also funds development of candidate therapeutic medical countermeasures to mitigate the consequences of exposure to ionizing radiation due to nuclear or radiological attacks. This Program Element focuses on efforts associated with advanced technology development used to demonstrate general military utility to include ACD&P in the areas of Non-Traditional Agents (NTA) and chemical/biological defense equipment and is correctly placed in BA4.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2011
Source ID
0603884BP_4_0400_PB_2011
Change Summary Explanation
Funding: FY09 - SBIR taxes (-$724K Various), Reprogrammings and realignments between projects (-$791 thousand CM4; +$2.4 million CP4; -$3.75 thousand DE4; +$2.373 million MB4; +$11.304 million MC4; -$3.740 million MR4). FY11 - Realignment to support Decontamination Family of Systems (+$7.1 million DE4). Inflation rate adjustment (-$300 thousand CA4; -$45 thousand CM4; -$33 thousand DE4; -$15 thousand IP4; -$53 thousand IS4; -$656 thousand MB4; -$92 thousand TE4; -$126 thousand TT4). Realignment of BA5 funding (SDD) to BA4 (ACD&P) due to change in acquisition milestone requirements (+$57.833 million CA4; +$9.593 million CM4; +$3.194 million IP4; +$11.3 million IS4). Realignment of CBDP to support test infrastructure (+$7.7 million TE4). Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical
  • Space

DTIC Thesaurus Topics

  • Aircrafts
  • Chemical Warfare
  • Chemical Warfare Agents
  • Detection
  • Detectors
  • Homeland Defense
  • Information Systems
  • Medical Personnel
  • Military Applications
  • Systems Engineering
  • Test And Evaluation
  • Test Equipment
  • Test Facilities
  • Test Methods
  • Therapy
  • Urban Areas
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.

Technology Areas

  • Biotechnology

Related Documents